---
title: "Keymed Biosciences, Inc. (2162) Receives a Buy from Sinolink Securities"
description: "Sinolink Securities analyst maintained a Buy rating on Keymed Biosciences, Inc. yesterday and set a price target of HK$83.29.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge fund-level data and "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/270822220.md"
published_at: "2025-12-26T05:05:27.000Z"
---

# Keymed Biosciences, Inc. (2162) Receives a Buy from Sinolink Securities

> Sinolink Securities analyst maintained a Buy rating on Keymed Biosciences, Inc. yesterday and set a price target of HK$83.29.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Keymed Biosciences, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$88.61.

Sinolink Securities analyst maintained a Buy rating on Keymed Biosciences, Inc. yesterday and set a price target of HK$83.29.

### Claim 70% Off TipRanks This Holiday Season

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Keymed Biosciences, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$88.61.

### Related Stocks

- [02162.HK - KEYMED BIO-B](https://longbridge.com/en/quote/02162.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Keymed Biosciences, Inc. (2162) Gets a Buy from Huatai Securities | Huatai Securities has maintained a Buy rating on Keymed Biosciences, Inc. (2162) with a price target of HK$91.08. Additi | [Link](https://longbridge.com/en/news/264562252.md) |
| Morgan Stanley Sticks to Its Buy Rating for Keymed Biosciences, Inc. (2162) | Lin covers the Healthcare sector, focusing on stocks such as HUTCHMED, HUTCHMED (China) , and Innovent Biologics. Accord | [Link](https://longbridge.com/en/news/258383362.md) |
| FAB Affirms Emaar Properties at Buy Following Robust FY25 Results | FAB Affirms Emaar Properties at Buy Following Robust FY25 Results | [Link](https://longbridge.com/en/news/276332897.md) |
| Bank of America Securities Sticks to Its Buy Rating for MKS (MKSI) | Bank of America Securities analyst Michael Mani has maintained a Buy rating on MKS (MKSI) with a price target of $300. C | [Link](https://longbridge.com/en/news/276348145.md) |
| Do Wall Street Analysts Like Ecolab Stock? | Do Wall Street Analysts Like Ecolab Stock? | [Link](https://longbridge.com/en/news/276322789.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.